Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
Biobanking
10 reasons to automate your nucleic acid separation workflow.
April 30, 2024 -
2 min read
Cell and Gene Therapy
6 factors for improving cell counting results.
April 30, 2024 -
2 min read
Drug Development
Improving drug safety through cardiotoxicity assessment.
April 29, 2024 -
2 min read
NGS
Existing depletion technologies for Next-Generation Sequencing (NGS).
April 26, 2024 -
2 min read
Cancer
Fluorescence imaging is comparable to PET in early detection of tumor metabolism.
April 25, 2024 -
4 min read
Cancer
The top 7 attributes of cell line-derived reference standards for oncology assays.
April 25, 2024 -
2 min read
Cell and Gene Therapy
The future of cell and gene therapy: Revvity at ASGCT.
April 23, 2024 -
2 min read
NGS
Limitations associated with the lack of data analysis tools in metagenomics.
April 16, 2024 -
2 min read
